Asep Medical Holdings Inc (SEPSF)
USD 0.39
(0.0%)
USD 0.39
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.05 Million CAD | 477.83% |
| 2022 | 528.16 Thousand CAD | 266.26% |
| 2021 | 144.2 Thousand CAD | -10.72% |
| 2020 | 161.51 Thousand CAD | 29.18% |
| 2019 | 125.02 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 3.47 Million CAD | 13.98% |
| 2024 Q2 | 4.05 Million CAD | 16.49% |
| 2023 Q1 | 511.08 Thousand CAD | -3.23% |
| 2023 Q3 | 648.97 Thousand CAD | -14.35% |
| 2023 Q4 | 3.05 Million CAD | 370.26% |
| 2023 FY | 3.05 Million CAD | 477.83% |
| 2023 Q2 | 757.67 Thousand CAD | 48.25% |
| 2022 Q1 | 78.85 Thousand CAD | -45.32% |
| 2022 FY | 528.16 Thousand CAD | 266.26% |
| 2022 Q3 | 965.78 Thousand CAD | 292.01% |
| 2022 Q4 | 528.16 Thousand CAD | -45.31% |
| 2022 Q2 | 246.36 Thousand CAD | 212.45% |
| 2021 FY | 144.2 Thousand CAD | -10.72% |
| 2021 Q3 | 3.38 Million CAD | 0.0% |
| 2021 Q4 | 144.2 Thousand CAD | -95.74% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Qrons Inc. | 1.48 Million USD | -105.0% |
| Capstone Therapeutics Corp. | 50.26 Million USD | 93.928% |
| Skye Bioscience, Inc. | 14.07 Million USD | 78.313% |
| Santhera Pharmaceuticals Holding AG | 59.01 Million USD | 94.829% |
| Nascent Biotech, Inc. | 808.79 Thousand USD | -277.335% |
| Adynxx, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 201.11 Thousand USD | -1417.463% |
| BioStem Technologies, Inc. | 15.9 Million USD | 80.812% |
| CSL Limited | 18.62 Billion USD | 99.984% |
| Evofem Biosciences, Inc. | 72.47 Million USD | 95.789% |
| Arch Therapeutics, Inc. | 9.46 Million USD | 67.759% |
| Regen BioPharma, Inc. | 5.45 Million USD | 44.081% |
| Northwest Biotherapeutics, Inc. | 74.92 Million USD | 95.927% |
| ProtoKinetix, Incorporated | 44.69 Thousand USD | -6728.041% |
| Rebus Holdings, Inc. | 5.24 Million USD | 41.781% |
| Burzynski Research Institute, Inc. | 27.43 Thousand USD | -11024.78% |
| Neon Bloom, Inc. | 1.22 Million USD | -148.885% |
| Eiger BioPharmaceuticals, Inc. | 53.3 Million USD | 94.275% |
| Nanobac Pharmaceuticals, Incorporated | 9.58 Million USD | 68.15% |
| Institute of Biomedical Research Corp. | 421.56 Thousand USD | -623.931% |
| SQZ Biotechnologies Company | 50.03 Million USD | 93.901% |
| Intellipharmaceutics International Inc. | 12 Million USD | 74.586% |
| Propanc Biopharma, Inc. | 3.85 Million USD | 20.76% |
| Mesoblast Limited | 188.44 Million USD | 98.38% |
| Marizyme, Inc. | 26.67 Million USD | 88.559% |
| Genus plc | 485 Million USD | 99.371% |
| VioQuest Pharmaceuticals, Inc. | 5.84 Million USD | 47.766% |
| Pharming Group N.V. | 244.07 Million USD | 98.75% |
| Therapeutic Solutions International, Inc. | 2.01 Million USD | -51.824% |
| CNBX Pharmaceuticals Inc. | 2.51 Million USD | -21.282% |
| Nymox Pharmaceutical Corporation | 3.8 Million USD | 19.688% |
| ContraFect Corporation | 32.53 Million USD | 90.619% |
| PsyBio Therapeutics Corp. | 1.98 Million USD | -54.033% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 3.82 Million USD | 20.268% |
| IMV Inc. | 37.93 Million USD | 91.955% |
| AXIM Biotechnologies, Inc. | 11.77 Million USD | 74.089% |
| MultiCell Technologies, Inc. | 1617.67 USD | -188557.823% |
| ONE Bio Corp. | 27.49 Million USD | 88.901% |
| Accustem Sciences Inc. | 1.07 Million USD | -182.779% |
| RVL Pharmaceuticals plc | 77.41 Million USD | 96.058% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 2.11 Million USD | -44.291% |
| Q BioMed Inc. | 8.13 Million USD | 62.475% |
| Emmaus Life Sciences, Inc. | 82.93 Million USD | 96.32% |
| Mosaic ImmunoEngineering Inc. | 5.14 Million USD | 40.695% |
| Biomind Labs Inc. | 1.49 Million USD | -103.646% |
| American Oriental Bioengineering, Inc. | 118.72 Million USD | 97.429% |
| Provectus Biopharmaceuticals, Inc. | 9.04 Million USD | 66.249% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 18.4 Million USD | 83.417% |
| GlobeStar Therapeutics Corporation | 1.43 Million USD | -112.842% |
| THC Farmaceuticals, Inc. | 142.09 Thousand USD | -2047.761% |
| Curative Biotechnology, Inc. | 5.74 Million USD | 46.886% |
| GB Sciences, Inc. | 5.41 Million USD | 43.667% |
| Alpha Cognition Inc. | 7.16 Million USD | 57.405% |
| HST Global, Inc. | 593.59 Thousand USD | -414.134% |
| Wesana Health Holdings Inc. | 1.25 Million USD | -142.366% |
| Halberd Corporation | 728.71 Thousand USD | -318.798% |
| Enzolytics Inc. | 365.26 Million USD | 99.164% |
| Agentix Corp. | 2.51 Million USD | -21.561% |
| Resverlogix Corp. | 67.39 Million USD | 95.472% |
| Nuo Therapeutics, Inc. | 838.73 Thousand USD | -263.866% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 444.95 Million USD | 99.314% |
| Enzon Pharmaceuticals, Inc. | 1.71 Million USD | -78.055% |
| Endonovo Therapeutics, Inc. | 24.74 Million USD | 87.667% |
| RespireRx Pharmaceuticals Inc. | 11.9 Million USD | 74.361% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.66 Million USD | 16.733% |
| AVAX Technologies, Inc. | 3.99 Million USD | 23.584% |
| Zenith Capital Corp. | 27.56 Thousand USD | -10969.901% |
| Genscript Biotech Corporation | 1.32 Billion USD | 99.77% |
| Ember Therapeutics, Inc. | 238.65 Thousand USD | -1178.781% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 3.73 Million USD | 18.275% |
| WPD Pharmaceuticals Inc. | 680.83 Thousand USD | -348.253% |
| Cotinga Pharmaceuticals Inc. | 2.71 Million USD | -12.547% |
| Kadimastem Ltd | 3.5 Million USD | 12.925% |
| Helix BioMedix, Inc. | 66.92 Thousand USD | -4459.848% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 464.69 Thousand USD | -556.739% |
| LadRx Corporation | 2.2 Million USD | -38.688% |
| Cell Source, Inc. | 15.8 Million USD | 80.693% |
| Regen BioPharma, Inc. | 5.45 Million USD | 44.081% |
| NovAccess Global Inc. | 7.86 Million USD | 61.176% |
| Affymax, Inc. | 8.87 Million USD | 65.597% |
| Itoco Inc. | 1.65 Million USD | -84.609% |
| Rasna Therapeutics, Inc. | 2.05 Million USD | -48.758% |
| Pathfinder Cell Therapy, Inc. | 6.04 Million USD | 49.548% |
| Mobile Lads Corp. | 1.31 Million USD | -132.346% |
| CytoDyn Inc. | 127.89 Million USD | 97.614% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 41.79 Thousand USD | -7201.278% |
| NanoSphere Health Sciences Inc. | 1.56 Million USD | -94.836% |
| Alseres Pharmaceuticals, Inc. | 11.04 Million USD | 72.37% |
| SYBLEU INC | 681.41 Thousand USD | -347.872% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 6.1 Million USD | 49.985% |
| International Stem Cell Corporation | 5.27 Million USD | 42.167% |
| Bioxytran, Inc. | 3.24 Million USD | 6.082% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 625.8 Thousand USD | -387.667% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 4.61 Million USD | 33.901% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 40.99 Million USD | 92.556% |
| Adhera Therapeutics, Inc. | 22.26 Million USD | 86.293% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 2.02 Million USD | -50.68% |
| Innovation Pharmaceuticals Inc. | 5.47 Million USD | 44.289% |
| Neutra Corp. | 973.52 Thousand USD | -213.484% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | 89.482% |
| PureTech Health plc | 125.58 Million USD | 97.57% |
| Coeptis Therapeutics, Inc. | 3.75 Million USD | 18.771% |
| IXICO plc | 1.9 Million USD | -60.6% |
| IntelGenx Technologies Corp. | 20.52 Million USD | 85.134% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 97.046% |
| CSL Limited | 18.62 Billion USD | 99.984% |
| Cellectis S.A. | 249.36 Million USD | 98.776% |